Crown Equity Holdings, Inc. financial data

Symbol
CRWE on OTC
Location
11226 Pentland Downs St., Las Vegas, NV
State of incorporation
NV
Fiscal year end
December 31
Former names
MICRO BIO-MEDICAL WASTE SYSTEMS, INC. (to 11/26/2007), 20/20 NETWORKS INC (to 5/23/2006), 20/20 WEB DESIGN INC (to 2/10/2003)
Latest financial report
10-Q - Q3 2024 - Nov 19, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.85 % +205%
Debt-to-equity -100 % +6.31%
Return On Equity 910 % +7366%
Return On Assets -106K % -3021%
Operating Margin -324K % -98.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 15.8M shares
Common Stock, Shares, Outstanding 15.8M shares +18.3%
Entity Public Float 1.28M USD -68.4%
Common Stock, Value, Issued 15.8K USD +18.4%
Weighted Average Number of Shares Outstanding, Basic 16M shares +19.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 943 USD +825%
Research and Development Expense 0 USD
General and Administrative Expense 2.03M USD +1156%
Operating Income (Loss) -3.05M USD -1734%
Nonoperating Income (Expense) -2.39M USD -40861%
Net Income (Loss) Attributable to Parent -5.44M USD -3059%
Earnings Per Share, Basic -0.23 USD/shares -2400%
Earnings Per Share, Diluted -0.23 USD/shares -2400%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.62K USD +131%
Assets, Current 3.54K USD +53.4%
Property, Plant and Equipment, Net 0 USD -100%
Assets 3.54K USD +51.3%
Liabilities, Current 309K USD -78.7%
Liabilities 309K USD -78.7%
Common Stocks, Including Additional Paid in Capital 13.4K USD +0.08%
Retained Earnings (Accumulated Deficit) -18.6M USD -31.1%
Stockholders' Equity Attributable to Parent -305K USD +78.9%
Liabilities and Equity 3.54K USD +51.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -21.9K USD +16.2%
Net Cash Provided by (Used in) Financing Activities 23K USD -24.5%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 450M shares 0%
Common Stock, Shares, Issued 15.8M shares +18.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -817 USD -162%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 2.96K USD +28.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 1.35M USD +46.3%
Depreciation 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 1.35M USD +46.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares +0.01%
Additional Paid in Capital 18.3M USD +43.5%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 18.7K USD +220%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%